Biologic Therapy


Tecentriq™ (June 8, 2016)

Class: Biological Therapy Generic Name: Atezolizumab Trade Name: Tecentriq™ How is this drug used? Tecentriq is approved for patients with advanced urothelial carcinoma (bladder cancer) whose disease... Continue Reading

Atezolizumab (June 8, 2016)

Class: Biological Therapy Generic Name: Atezolizumab Trade Name: Tecentriq™ How is this drug used? Tecentriq is approved for patients with advanced urothelial carcinoma (bladder cancer) whose disease... Continue Reading

Praxbind® (May 17, 2016)

Class: Biologic Therapy Generic Name: idarucizumab Trade Name: Praxbind For which conditions is this drug approved? Praxbind® is indicated for patients specifically treated with Pradaxa® (dabigatran... Continue Reading

idarucizumab (May 17, 2016)

Class: Biologic Therapy Generic Name: idarucizumab Trade Name: Praxbind For which conditions is this drug approved? Praxbind® is indicated for patients specifically treated with Pradaxa® (dabigatran... Continue Reading

Venclexta® (May 12, 2016)

Class: Biological Therapy Generic Name: Venetoclax Trade Name: Venclexta® How is this drug used? Venclexta is approved for the treatment of patients with chronic lymphocytic leukemia (CLL) who have... Continue Reading

Venetoclax (May 12, 2016)

Class: Biological Therapy Generic Name: Venetoclax Trade Name: Venclexta® How is this drug used? Venclexta is approved for the treatment of patients with chronic lymphocytic leukemia (CLL) who have... Continue Reading

Cabometyx™ (May 12, 2016)

Class: Biological Therapy Generic Name: Cabozantinib Trade Name: Cabometyx™ How is this drug used? Cabometyx is approved for patients with advanced renal cell carcinoma (RCC) who have already been... Continue Reading

Cabozantinib (May 12, 2016)

Class: Biological Therapy Generic Name: Cabozantinib Trade Name: Cabometyx™ How is this drug used? Cabometyx is approved for patients with advanced renal cell carcinoma (RCC) who have already been... Continue Reading

Crizotinib (May 6, 2016)

Class: Biological Therapy Generic Name: Crizotinib Trade Name: Xalkori® How is this drug used? Xalkori is used for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) whose... Continue Reading

Imlygic™ (April 6, 2016)

Class: Viral Therapy Generic Name: talimogene laherparepvec Trade Name: Imlygic™ For which conditions is this drug approved? Imlygic can be used to treat melanomas in the skin or lymph nodes that... Continue Reading

talimogene laherparepvec (April 6, 2016)

Class: Viral Therapy Generic Name: talimogene laherparepvec Trade Name: Imlygic™ For which conditions is this drug approved? Imlygic can be used to treat melanomas in the skin or lymph nodes that... Continue Reading

Cotellic™ (April 6, 2016)

Class: Biological Therapy Generic Name: cobimetinib Trade Name: Cotellic™ For which conditions is this drug approved? Cotellic is a kinase inhibitor used for the treatment of patients with unresectable... Continue Reading

cobimetinib (April 6, 2016)

Class: Biological Therapy Generic Name: cobimetinib Trade Name: Cotellic™ For which conditions is this drug approved? Cotellic is a kinase inhibitor used for the treatment of patients with unresectable... Continue Reading

Tagrisso (March 28, 2016)

Class: Biological Therapy Generic Name: Osimertinib Trade Name: Tagrisso™ For which conditions is this drug approved? Tagrisso is a kinase inhibitor used to treat patients with metastatic epidermal... Continue Reading

Osimertinib (March 28, 2016)

Class: Biological Therapy Generic Name: Osimertinib Trade Name: Tagrisso™ For which conditions is this drug approved? Tagrisso is a kinase inhibitor used to treat patients with metastatic epidermal... Continue Reading

Darzalex™ (March 24, 2016)

Class: Biological Therapy Generic Name: daratumumab Trade Name: Darzalex™ How is this drug used? DARZALEX is indicated for the treatment of patients with multiple myeloma who have received at least... Continue Reading

daratumumab (March 24, 2016)

Class: Biological Therapy Generic Name: daratumumab Trade Name: Darzalex™ How is this drug used? DARZALEX is indicated for the treatment of patients with multiple myeloma who have received at least... Continue Reading

Ninlaro® (February 11, 2016)

Class: Biological Therapy Generic Name: Ixazomib Trade Name: Ninlaro® For which conditions is this drug approved? Ninlaro is approved for use in combination with the medicines Revlimid® (lenalidomide)... Continue Reading

Next Page »

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS